Filter This View

  • December 14, 2012 |

    Jones Day makes up 45 new partners, including six in London

    Jones Day has made up 45 new partners, including six in London, marking the latest US firm to announce its annual promotions. The new City partners are split across the firm's practices and comprise: Liz Robertson (M&A); Amy Koh (banking and finance); Matt Evans (competition); Simon Kiff (M&A); Anna Cartwright (private equity); and Lucas Moore (dispute resolution).

    1 minute read

  • December 13, 2012 |

    Litigation and Regulatory Team of the Year: Stephenson Harwood

    This was one of the strongest fields in this year's awards, with many firms standing out. Jones Day was praised for its proactive advocacy for Duff & Phelps as liquidators of Weavering Capital on the largest-ever hedge fund fraud in Europe. The law firm not only achieved success in a $450m (£283m) damages claim but effectively ensured that a criminal investigation and prosecution would take place, despite resistance from UK prosecutors.

    1 minute read

  • December 13, 2012 |

    Assistant Solicitor/Associate of the Year: Sarah Batley

    Sarah Batley stood head and shoulders above the competition to take the accolade of Assistant Solicitor/Associate of the Year. As a young litigator with only two years' post-qualification experience, she was singled out as a "clear winner" by one judge. In the last year, Batley has acted as lead associate on five complex cases, attracting a string of complimentary feedback from clients and counsel.

    1 minute read

  • December 13, 2012 |

    Hogan Lovells eyes move into Mexico amid Latin America boom

    Hogan Lovells is eyeing up a move into Mexico, as interest from global law firms in the Latin American markets continues to grow. The transatlantic firm confirmed it is considering opening in the country, with all options up for debate including an acquisition, an alliance and a joint venture.

    1 minute read

  • December 13, 2012 |

    British Legal Awards 2012: who won what – and why...

    A full run-down of all the winners at the British Legal Awards 2012

    1 minute read

  • November 22, 2012 |

    Travers takes top law firm prize at British Legal Awards 2012

    Travers Smith, Norton Rose and LV= were among the prize winners at last night's (22 November) British Legal Awards, which took place at London's Old Billingsgate Market. Travers saw off competition from Berwin Leighton Paisner, Clifford Chance, Latham & Watkins, Mishcon de Reya and Olswang to scoop the coveted Law Firm of the Year award.

    1 minute read

  • November 21, 2012 |

    The Transfer Window: recent moves including White & Case, Stephenson Harwood and A&O

    US firm Goodwin Procter has added a fifth partner to its London office with the hire of Allen & Overy (A&O) tax counsel Ben Eaton. Eaton, whose tax practice focuses on investment funds and real estate transactions, also has broad tax experience of private equity, infrastructure and renewables, debt, hedge funds and real estate.

    1 minute read

  • November 19, 2012 |

    Jones Day and SJB bulk up in Germany with team hires

    Jones Day has boosted its recently launched Duesseldorf base with the hire of a team from Luther, while SJ Berwin has also bulked up in Germany with a double partner hire from White & Case. Luther banking partner Claudia Leyendecker is joining Jones Day's Duesseldorf base - which opened in February this year - alongside three lawyers. She has been an equity partner at Luther since 2008.

    1 minute read

  • November 15, 2012 |

    SNR Denton aims to dramatically reinvent global brand with Salans and FMC unions

    Dentons' leaders tell Alex Newman why their 'polycentric' merger can refashion the firm as a true global challenger...

    1 minute read

  • November 8, 2012 |

    UK duo act as Japan pharma co takes GSK-Pfizer JV stake

    Allen & Overy (A&O) and Slaughter and May are among a line-up of top law firms advising on Japanese pharma group Shionogi's purchase of a 10% stake in Pfizer and GlaxoSmithKline's (GSK) joint venture ViiV Healthcare.

    1 minute read